Amit Hasija

Amit Hasija

Chief Financial Officer and Executive Vice President of Corporate DevelopmentatMilestone Pharmaceuticals· In proxies 2022–2025

Pay in FY2025Milestone Pharmaceuticals stock -14.4% the same year

Amit Hasija was paid $991.9K in FY2025 (Dec). Milestone Pharmaceuticals stock fell 14.4% that year.

Pay$100 in the stock at the end of FY21 → $52
Pay is from the Summary Compensation Table of each Milestone Pharmaceuticals proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Milestone PharmaceuticalsPublic company · 4 yr
    • Chief Financial Officer and Executive Vice President of Corporate Development2022 – Present · 4 yrStock in role -89%

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

Two people shown as one, or a wrong number?